Intravenous Infusions Plc Announces Audited Earnings Results for the Year Ended December 31, 2017
Intravenous Infusions Plc announced audited earnings results for the year ended December 31, 2017. For the year, the company’s revenue was GHS 16,371,794 compared to GHS 10,596,009 a year ago. PBDIT was GHS 4,648,771 compared to GHS 1,972,685 a year ago. PBIT was GHS 4,161,419 compared to GHS 1,684,448 a year ago. Profit before tax was GHS 3,251,228 compared to GHS 1,168,652 a year ago. Profit after tax was GHS 2,730,682 compared to GHS 669,945 a year ago. Basic and diluted EPS was GHS 0.01205 compared to GHS 0.00296 a year ago. Net cash used in operating activities was GHS 637,701 compared to GHS 4,299,593 a year ago. Cash paid for property, plant and equipment was GHS 1,242,467 compared to GHS 803,769 a year ago.